Vaccine Partnership discussed between India and USA

A meeting was held between, S Jaishankar Indian External Affairs Minister and Antony Blinken US Secretary of State in Washington on 28th May, 2021.

A productive discussion was held between them on various aspects of bilateral cooperation and other global & regional issues. They discussed about Indo Pacific Quad, the matter of Myanmar, matters related to Afghanistan and other matters related to UNSC. This meeting also focused on an Indo-US vaccine partnership.

Indo-US vaccine partnership

The main aim of this partnership is to ensure supply and expand access of the COVID-19 vaccines. Following the meeting, The United States government issued fresh orders to redirect critical vaccine manufacturing supplies to India. This will now allow India to make over 20 million additional doses of the AstraZeneca COVID-19 vaccine and will help in the vaccination plans of the country.

USA cooperation regarding COVID

From the month of June, 2021, USA has announced its plans to send 60 million doses of the AstraZeneca vaccine to other nations fighting the COVID-19 pandemic. The government of USA has also provided over 500 million dollars in the form of relief supplies to India to help the country in its fight against the pandemic.

About AstraZeneca

The Oxford-AstraZeneca covid-19 vaccine has been developed by the British-Swedish multinational pharmaceutical and Biotechnology Company. It’s headquarter is located at Cambridge Biomedical Campus in Cambridge, England. It has developed various products for some major diseases in the fields of cardiovascular, infection, oncology, neuroscience, gastrointestinal and respiratory.

In India the Oxford-AstraZeneca vaccine is manufactured by Serum India. It is named CoviShield.

About United States of America

President: Joe Biden

Vice President: Kamala Harris


Leave a Reply